ArticleBMJ open2024

Randomised, double-blind, placebo-controlled study evaluating the effect of allopurinol on the risk of cardiovascular events in patients with high and very high cardiovascular risk, including the presence of long-COVID-19 syndrome: the ALL-VASCOR study protocol.

Katarzyna Lewandowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.